Boston Scientific (NYSE:BSX) has reportedly confirmed job losses at its Galway, Ireland, location, following the retirement of the Lotus Edge. Galway Bay FM reported today that the Marlborough, Mass.-based company confirmed the job losses at its Ireland location, adding that Boston Scientific confirmed the job loss will affect fewer than 30 employees. The report said that […]
tavr
MedTech 100 roundup: Industry remains strong despite slight dip
The heights of two weeks ago may not have been reached, but the medtech industry — despite a slight dip — performed well in the stock markets once again. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week at 97.99 (Nov. 20), marking a 1% downturn […]
Boston Scientific to lay off 106 following Lotus Edge heart valve retirement
Boston Scientific (NYSE:BSX) is set to lay off 106 employees in Minnesota following the retirement of its Lotus Edge device, according to reports. Bring Me the News reported that the company is permanently laying off the 106 workers at its Maple Grove, Minn. location, having notified the state of Minnesota via a WARN letter, as is […]
Boston Scientific throws in the towel on Lotus TAVR
Boston Scientific (NYSE:BSX) announced today that it has initiated a global, voluntary recall of its Lotus Edge aortic valve system — and is immediately retiring the Lotus program. Marlborough, Mass.-based Boston Scientific said in a news release that the recall of all unused inventory of its Lotus Edge transcatheter aortic valve repair (TAVR) system is due […]
Medtronic updates instructions for potential risks with CoreValve R, CoreValve Pro TAVR devices
Medtronic (NYSE:MDT) issued a field safety notice to provide updates on rare potential risks with some of its TAVR devices. The CoreValve Evolut R and CoreValve Evolut Pro devices were listed in the notice as devices for which there were updates to the instructions for use manuals, specifically regarding the risk of transcatheter aortic valve (TAV) […]
Edwards reports better-than-expected Q3 results
Edwards Lifesciences (NYSE:EW) shares hardly moved after hours on third-quarter results that came in ahead of the consensus forecast. The Irvine, Calif.-based company posted profits of $325.2 million, or 52¢ per share, on sales of $1.14 billion for the three months ended Sept. 30, 2020, for an 18.4% bottom-line gain on sales growth of 4.3%. Adjusted […]
Medtronic CEO Geoff Martha: ‘Time to be bold and add grit’
Medtronic (NYSE:MDT) CEO Geoff Martha has no intention of slowing the medtech giant down amid the COVID-19 pandemic. Speaking during the Fridley, Minn.-based company’s “Investor Day” virtual presentation, Martha made one thing clear: “We are going on the offensive,” Martha said at the start and echoed throughout the program. About six months into his tenure as […]
Medtronic launches head-to-head TAVR study against Edwards
Medtronic (NYSE:MDT) today announced it will begin a randomized, head-to-head study comparing two transcatheter aortic valve replacement (TAVR) systems in patients with severe symptomatic aortic stenosis (ssAS), primarily in women. The postmarket SMART trial will compare valve safety and performance of the self-expanding Medtronic Evolut PRO and PRO+TAVR Systems against Edwards Lifesciences’ (NYSE:EW) balloon-expandable SAPIEN 3 and […]
AI could boost Edwards’ critical care business
Critical care comprises nearly 20% of Edwards’ revenue. Its continued growth is connected to the prominence of the company’s heart valve business. Katie Szyman spent 23 years at Medtronic, a giant in the Medtech industry, but a patient-focused outlook became a driving force behind a change for her. Wanting to work for a California-based company […]
Which TAVR device is the best? It depends, researchers say
Researchers published a paper in the Journal of the American Medical Association citing insufficient evidence regarding the superiority of TAVR devices. Currently, only three TAVR devices are commercially available in the U.S., belonging to Edwards Lifesciences (NYSE:EW), Medtronic (NYSE:MDT) and Boston Scientific (NYSE:BSX), although several others are being used in clinical trials to evaluate safety and efficacy. Get the full story at our […]
MedTech 100 roundup: Industry reaches new heights again
The past month has seen a resurgence from medtech companies in the markets and last week saw the best performance yet. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 90.78 points at the end of last week (Aug. 28). Overall, medtech stocks saw a 1.3% increase […]
